Opexa Therapeutics (OPXA) Misses Q2 EPS by 7c

August 11, 2016 4:19 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Opexa Therapeutics (NASDAQ: OPXA) reported Q2 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment